Menu

Market Research

Botulinum Toxin Market 2021-2026: Global Size, Share, Trends and Forecast Report

According to the latest report by IMARC Group, titled “Botulinum Toxin Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, the global botulinum toxin market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Report Sample: https://www.imarcgroup.com/botulinum-toxin-market/requestsample

Botulinum toxin refers to a neurotoxin manufactured by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod that is commonly found in soil, plants, water, the intestinal tracts of several animals, etc. Botulinum toxin plays a significant role in the management of various medical conditions, such as strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, spastic movement disorders, etc. It is also utilized for numerous cosmetic purposes, including to temporarily reduce frown lines, creases, and wrinkles on the face, chin, neck, chest, etc.

The increasing product utilization in the treatment of numerous dermatological conditions, such as abnormal gland activity and overactive smooth muscles, is primarily driving the botulinum toxin market across the globe. Additionally, the growing beauty consciousness among individuals and their willingness to undergo reconstructive and cosmetic surgeries are also propelling the market growth. Apart from this, the inflating levels of disposable incomes and urbanization, coupled with the emerging trend of cosmetic tourism, are acting as significant growth-inducing factors. Moreover, the expanding geriatric population is further catalyzing the market growth since the skin becomes more susceptible to sagging and wrinkles with age. In addition to this, various technological innovations, such as the development of new potent toxins to enhance the effectiveness of antigenic dose, are projected to bolster the botulinum toxin market in the coming years.

Botulinum Toxin Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the global botulinum toxin market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • AbbVie Inc.
  • Eisai Co. Ltd
  • Evolus Inc
  • Galderma SA
  • HUGEL Inc.
  • Ipsen Group
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Metabiologics Inc.
  • Revance Therapeutics Inc.

Key Market Segmentation:

The report has segmented the global botulinum toxin market on the basis of type, application, end user and region.

Breakup by Type:

  • Toxin Type A
  • Toxin Type B

Breakup by Application:

  • Therapeutics
  • Aesthetics

Breakup by End User:

  • Hospitals and Clinics
  • Dermatology Clinics
  • Spas and Cosmetic Centres

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/botulinum-toxin-market

Key highlights of the report:            

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Industry Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Go Back

Comment